Lunit nabs approval for AI software in Taiwan

2020 03 04 21 21 6197 Artificial Intelligence Ai Hand 400 20200304215813

Artificial intelligence (AI) software developer Lunit has received commercial approval in Taiwan for its software product for mammography analysis.

Lunit Insight MMG is one of the company's most mature radiology products. The AI software analyzes mammography images to detect suspicious lesions in mammography images, helping radiologists distinguish suspected tumor areas by providing the location of the lesion with an abnormality score reflecting the AI's confidence level, Lunit said.

Lunit Insight MMG was cleared by the U.S. Food and Drug Administration last year and by Health Canada in June.

Page 1 of 569
Next Page